» Articles » PMID: 25969671

Autoinflammatory Diseases: a Possible Cause of Thrombosis?

Overview
Journal Thromb J
Publisher Biomed Central
Date 2015 May 14
PMID 25969671
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Autoinflammatory diseases are a group of disorders due to acquired or hereditary disfunction of innate immune system and characterized by systemic or localized manifestations. The prototype is Familial Mediterranean Fever, a monogenic hereditary disorder, whose causing gene (MeFV gene) was identified in 1997 and opened the way to a new fascinanting chapter of rheumatology. A growing body of monogenic and poligenic autoinflammatory disorders has been described since then. Arterial and venous thrombosis is a common medical problem, with significant morbidity and mortality. Strong evidences from basic research and clinical epidemiological studies support the theory that inflammation and thrombosis can be associated. Because of their recurrent/chronic inflammatory nature, autoinflammatory diseases are a putative cause of thrombotic manifestations. In the present work, we reviewed the available evidences about monogenic autoinflammatory disorders, complicated by thrombotic manifestations.

Citing Articles

An early warning indicator of mortality risk in patients with COVID-19: the neutrophil extracellular traps/neutrophilic segmented granulocyte ratio.

Wang Q, Qin Y, Ma J, Zhou K, Xia G, Li Y Front Immunol. 2024; 15:1287132.

PMID: 38348024 PMC: 10859410. DOI: 10.3389/fimmu.2024.1287132.


Increased risk of venous thromboembolism among patients with familial Mediterranean fever.

Gendelman O, Feifel A, Tsur A, Comanhester D, Cohen A, Amital H J Thromb Thrombolysis. 2022; 54(4):669-674.

PMID: 36239856 DOI: 10.1007/s11239-022-02711-8.


VEXAS Syndrome: A Novelty in MDS Landscape.

Temple M, Kosmider O Diagnostics (Basel). 2022; 12(7).

PMID: 35885496 PMC: 9315795. DOI: 10.3390/diagnostics12071590.


Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.

Obiorah I, Patel B, Groarke E, Wang W, Trick M, Ombrello A Blood Adv. 2021; 5(16):3203-3215.

PMID: 34427584 PMC: 8405186. DOI: 10.1182/bloodadvances.2021004976.


Autoinflammatory Diseases and Physical Therapy.

Gurcay E, Akinci A Mediterr J Rheumatol. 2020; 28(4):183-191.

PMID: 32185281 PMC: 7046004. DOI: 10.31138/mjr.28.4.183.

References
1.
Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H . Is Familial Mediterranean Fever a thrombotic disease or not?. Eur J Pediatr. 2007; 167(3):279-85. DOI: 10.1007/s00431-007-0475-2. View

2.
Feld O, Yahalom G, Livneh A . Neurologic and other systemic manifestations in FMF: published and own experience. Best Pract Res Clin Rheumatol. 2012; 26(1):119-33. DOI: 10.1016/j.berh.2012.01.004. View

3.
Kalyoncu U, Eker A, Oguz K, Kurne A, Kalan I, Topcuoglu A . Familial Mediterranean fever and central nervous system involvement: a case series. Medicine (Baltimore). 2010; 89(2):75-84. DOI: 10.1097/MD.0b013e3181d5dca7. View

4.
Atagunduz P, Ergun T, Direskeneli H . MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol. 2004; 21(4 Suppl 30):S35-7. View

5.
Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D . Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J. 2001; 3(1):9-12. View